Olanzapine for schizophrenia: Cochrane systematic review [sounds like]
25 results
1 - 25
Olanzapine for schizophrenia: Cochrane systematic review- Risperidone versus other atypical antipsychotic medication for schizophrenia: Cochrane systematic review
- Aripiprazole versus other atypical antipsychotics for schizophrenia: Cochrane systematic review
- Antipsychotic medication for elderly people with schizophrenia
- Oral paliperidone for schizophrenia: Cochrane systematic review
- Fluphenazine (oral) versus atypical antipsychotics for schizophrenia
- Newer atypical antipsychotic medication versus clozapine for schizophrenia: Cochrane systematic review
- Antipsychotic drug treatment for elderly people with late‐onset schizophrenia
- Aripiprazole versus placebo for schizophrenia: Cochrane systematic review
- Atypical antipsychotics for psychosis in adolescents: Cochrane systematic review
- Interventions for psychotic symptoms concomitant with epilepsy: Cochrane systematic review
- Haloperidol dose for the acute phase of schizophrenia
- Risperidone versus other antipsychotics for people with severe mental illness and co‐occurring substance misuse
- Early intervention for psychosis: Cochrane systematic review
- Aripiprazole (intramuscular) for psychosis‐induced aggression or agitation (rapid tranquillisation)
- Risperidone for psychosis‐induced aggression or agitation (rapid tranquillisation)
- Haloperidol plus promethazine for psychosis‐induced aggression